Literature DB >> 15627775

The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.

Jun Zhang1, Yiqing Song, Honglei Chen, Dongsheng Fan.   

Abstract

BACKGROUND: Polymorphisms in the tau gene may be associated with increased risk for idiopathic Parkinson's disease (PD); however, most of previous association studies have been underpowered to detect a potentially modest contribution of the tau variants to PD risk.
OBJECTIVE: To clarify the relationship between genetic variation in tau gene and PD risk, we conducted a meta-analysis of all published association studies. We identified 14 independent case-control studies including 2,093 PD cases and 2,258 controls. After excluding two studies contributing to most of between-study heterogeneity, the pooled odds ratios (OR) and 95% confidence intervals (CI) of PD were 1.42 (95% CI, 1.23-1.65) for those with H1/H1 genotype compared with all others and 1.52 (95% CI, 1.12-2.04) for all individuals carrying H1 haplotype versus all others. Based on the data available, the results were not significantly different according to sex, family history of PD, age at onset and dementia status.
CONCLUSIONS: Our results support the notion that tau gene H1 haplotype may be an important risk factor of PD. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627775     DOI: 10.1159/000082956

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  17 in total

Review 1.  Knock-out and transgenic mouse models of tauopathies.

Authors:  Franziska Denk; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-22       Impact factor: 4.673

2.  Exploring gene-environment interactions in Parkinson's disease.

Authors:  Colin C McCulloch; Denise M Kay; Stewart A Factor; Ali Samii; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Jennifer S Montimurro; Cyrus P Zabetian; Haydeh Payami
Journal:  Hum Genet       Date:  2008-01-22       Impact factor: 4.132

Review 3.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

4.  Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Authors:  Maria Elena Di Battista; Esterina Pascale; Carlo Purcaro; Francesca Passarelli; Emanuela Passarelli; Renzo Guglielmi; Nicola Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2013-11-20       Impact factor: 3.575

5.  Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings.

Authors:  Cristina Lorenzi; Alessandra Marcone; Adele Pirovano; Elena Marino; Francesco Cordici; Chiara Cerami; Dario Delmonte; Stefano F Cappa; Placido Bramanti; Enrico Smeraldi
Journal:  Neurol Sci       Date:  2010-09-18       Impact factor: 3.307

6.  Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Authors:  William Lin; Un Jung Kang
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

7.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Stewart A Factor; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Denise M Kay; Dora Yearout; Jennifer S Montimurro; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

Review 8.  Model fusion, the next phase in developing animal models for Parkinson's disease.

Authors:  Amy B Manning-Bog; J William Langston
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

9.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

10.  Merging mouse transcriptome analyses with Parkinson's disease linkage studies.

Authors:  Daniel Gherbassi; Lavinia Bhatt; Sandrine Thuret; Horst H Simon
Journal:  DNA Res       Date:  2007-05-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.